Data as of Nov 4, 2026.

vsOpen in the appCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Thematic ETFs

ARKG vs BBC: Holdings Overlap & Returns

Share
Share on XDownload as PDF

Over the year to Nov 4, 2026, ARKG returned +68.4% to BBC's +45.9%; 6% of their weight is in the same names.

askIQ about this page

askIQ about ARKG and BBC

Net assets: $2.1bn on Nov 2, 2026 for ARK Genomic Revolution ETF, and $46m on Jul 31, 2026 for Virtus Biotech Clinical Trials ETF.

At a glance
4.6%
ARKG in the S&P 500
0.0%
BBC in the S&P 500
+68.4%
ARKG total return, 1 year
+45.9%
BBC total return, 1 year
ARKG · 1 year to Nov 4, 2026 95% of its weight is outside the S&P 500
95% of its weight is outside the S&P 5005% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.5%95%inof its weight outside the S&P 500active share 99% · top ten 59% of the fund · 35 holdings as published by its issuer for Nov 2, 2026 · Nasdaq-100: 0% in95% of its weight is outside the S&P 5005% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.5%95%5% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 99% · Nasdaq-100: 0% in

5% of ARKG's weight is in S&P 500 companies and 95% is outside the index. Holdings as of Nov 2, 2026.

BBC · 1 year to Nov 4, 2026 100% of its weight is outside the S&P 500
100% of its weight is outside the S&P 5000% of BBC's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Jul 31, 2026.0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · top ten 12% of the fund · 131 holdings as filed for Jul 31, 2026 · Nasdaq-100: 0% in100% of its weight is outside the S&P 5000% of BBC's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Jul 31, 2026.0%100%0% of its weight in S&P 500 companiesof its weight outside the S&P 500active share 100% · Nasdaq-100: 0% in

0% of BBC's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Jul 31, 2026.

Pair scorecard

BBC costs 0.10 points a year less; their one-year returns differ by 22.5 points.

ARKG vs BBC: Holdings Overlap & Returns
MeasureARKGBBC
Return
Total return, 1 year+68.4%+45.9%
Drawdown
Below its all-time high55.5%, high on Jan 20, 202127.4%, high on Feb 8, 2021
Benchmark
What it tracksGenomics and gene editingBiotech
Cost and size
Expense ratio0.75%0.65%
Net assets, ARKG as of Nov 2, 2026 and BBC as of Jul 31, 2026$2.1bn$46m
Active share vs the S&P 50098%100%
Holdings
Holdings in common6%
Top ten holdings, share of the fund58%12%

Method

What they share

6%

By the books each fund has filed, ARKG and BBC hold 6% of their money in the same securities at the same weight. Holdings dated Jul 31, 2026 and Nov 2, 2026.

0 half 100%

half

6% in common

Positions both hold · largest shared weight first ARKG BBC
NURIX THERAPEUTICS INC 2.88% 0.92%
GENERATE BIOMEDICINES INC 1.04% 0.76%
PRIME MEDICINE INC 1.71% 0.70%
KYMERA THERAPEUTICS INC 0.70% 0.80%
RECURSION PHARMACEUTICALS-A 2.91% 0.64%
COMPASS PATHWAYS PLC 2.05% 0.63%
INTELLIA THERAPEUTICS INC 1.89% 0.59%
BEAM THERAPEUTICS INC 3.84% 0.59%
Only in one fund ↓
Only in ARKG
TEMPUS AI INC-CL A 9.85%
10X GENOMICS INC-CLASS A 7.52%
TWIST BIOSCIENCE CORP 7.42%
CRISPR THERAPEUTICS AG 5.48%
GUARDANT HEALTH INC 5.13%
ABSCI CORP 5.08%
NATERA INC 4.67%
ELI LILLY & CO 4.59%
Only in BBC
FIRST TRACKS BIOTHERAPEUTICS INC 1.67%
MBX BIOSCIENCES INC 1.24%
ATAIBECKLEY INC 1.23%
MONOPAR THERAPEUTICS INC 1.21%
DEFINIUM THERAPEUTICS INC 1.18%
XENCOR INC 1.10%
ZENAS BIOPHARMA INC 1.06%
UNIQURE NV 1.06%
Check overlap with more funds →

Window by window

Window by window: ARKG vs BBC: Holdings Overlap & Returns
Total return
WindowARKGBBC
3 months+20.5%−14.8%
6 months+60.0%−5.2%
1 year+68.4%+45.9%
3 years+90.8%+132.0%
Since launchNot the same days: ARKG Oct 2014 · BBC Dec 2014+164.2%+72.8%

Open this comparison in the app →

Side by side

ARKG ARK Genomic Revolution ETF · Holds 35 stocks in genomics and gene editing, 5% of its weight in S&P 500 companies BBC Virtus Biotech Clinical Trials ETF · Holds 131 stocks in biotech, 0% of its weight in S&P 500 companies
Issuer ARK Virtus
Theme Genomics and gene editing Biotech
In the S&P 500 4.6% 0.0%
Active share vs the S&P 500 98.5% 100.0%
In the Nasdaq-100 0.0% 0.0%
Holdings 35 131
Top ten, share of the fund 58.5% 11.8%
Expense ratio 0.75% 0.65%
Fee for the differing part 0.76% 0.65%
Total return, 1 year +68.4% +45.9%
vs its benchmark not measured not measured
Below its high −55.5% −27.4%
Net assets, ARKG as of Nov 2, 2026 and BBC as of Jul 31, 2026 $2.1bn $46m

As of Nov 4, 2026. Source: ETFIQ.

6% of the two portfolios are the same securities at the same weight.

Alert

The week's ETF fund flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
ARKG

By weight, 5% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 58% of the fund across 35 positions, as published by its issuer for Nov 2, 2026. Over the year to Nov 4, 2026 the fund returned +68.4% with distributions reinvested. It sits 55.5% below its all-time high of Jan 20, 2021.

BBC

By weight, 0% of BBC's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 12% of the fund across 131 positions, as filed for Jul 31, 2026. Over the year to Nov 4, 2026 the fund returned +45.9% with distributions reinvested. It sits 27.4% below its all-time high of Feb 8, 2021.

Questions people ask

Do ARKG and BBC hold the same stocks?
By their latest filings, 6% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Which is more different from the S&P 500, ARKG or BBC?
ARKG has 5% of its weight in S&P 500 names and BBC has 0%, so BBC differs more from the index.
Which is cheaper, ARKG or BBC?
ARKG charges 0.75% a year and BBC charges 0.65%, so BBC is cheaper. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, ARKG against BBC, data as of Nov 4, 2026. https://etfiq.com/compare/themes/arkg-vs-bbc

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.